SCHEMBL7079282

SCHEMBL7079282

Cc1ccccc1Nc1ccc(C(=S)c2nccnc2Cl)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 13/20 0.55
MAPK13 O15264 12/20 0.55
MAPK12 P53778 12/20 0.55
MAPK11 Q15759 12/20 0.55
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PTK6 Q13882 1/20 0.38
GRM4 Q14833 1/20 0.37
CCNA2 P20248 3/20 0.37
CDK2 P24941 3/20 0.37
CCNK O75909 2/20 0.37
CDK9 P50750 2/20 0.37
MAPK10 P53779 1/20 0.36
CCND3 P30281 1/20 0.36
CDK6 Q00534 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082606 0.88 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7591681 0.86 MAPK14 (0.42) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7080273 0.86 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11PTK6
SCHEMBL7566944 0.85 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7566947 0.84 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7081916 0.84 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11PTK6
SCHEMBL7081913 0.84 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11PTK6
SCHEMBL7076132 0.82 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL5174459 0.81 MAPK14 (0.71) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7075155 0.81 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.